Chempacific Corp, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GS22264 DRUG SUBSTANCE, with a corresponding US DMF Number 36659.
Remarkably, this DMF maintains an Active status since its submission on February 11, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 30, 2022, and payment made on May 25, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II